Overall Management > Ependymal TumorsStaging and Prognosis


Journal of Neuro-Oncology, 68 (3): 255-261, July 2004.(Retrospective Study)


Abstract

Multivariate Analysis of Clinical Prognostic Factors in Children with Intracranial Ependymomas

Tang-Her Jaing, Huei-Shyong Wang, Pei-Kwei Tsay, Chen-Kan Tseng, Shih-Ming Jung, Kuang-Lin Lin, Tai-Ngar Lui

Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Children's Hospital, Taoyuan, Taiwan (T.-H.J.); Division of Neurology, Department of Pediatrics, Chang Gung Children's Hospital, Kwei-Shan 333, Taoyuan, Taiwan (H.-S.W., K.-L.L.); Department of Public Health and Center of Biostatistics, College of Medicine, Chang Gung University, Taoyuan, Taiwan (P.-K.T.); Department of Radiation Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan (C.-K.T.); Department of Pathology, Chang Gung Memorial Hospital, Taoyuan, Taiwan (S.-M.J.); Division of Neurosurgery, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan (T.-N.L)

The optimal postoperative management of pediatric intracranial ependymomas is controversial. 
We analyzed clinical prognostic factors for their influence on outcome in such children. 
Our retrospective series included 15 with supratentorial and 28 with infratentorial tumors. 
Twenty ependymomas were grade II, and 23 were anaplastic. 
Complete resection was performed in 18 patients, incomplete resection in 19, and stereotactic biopsy in 6. 
Radiotherapy was done in 31 patients and chemotherapy in 13. 
The surviving patients have been followed 8232 months (median: 69 months). 
The median survival time was 30 months, and 5-year overall survival and progression-free survival rates were 53.9% and 45.9%, respectively. 
By tumor site: supratentorial, 56.6% and 50.9%; infratentorial, 52.3% and 42.5%. 
Multivariate analysis identified complete resection (5-year progression-free survival, 71.8%) and age <3 years old as significant favorable and adverse prognostic features (relative risk, 2.59; 95% CI, 1.056.38), respectively. 
Twenty-six children relapsed 1107 months after diagnosis (median: 12 months). 
Relapses were local in 22 cases, and combined local and distant in three cases. 
Only one of 15 patients with supratentorial tumors developed isolated spinal metastasis. 
Failure at the primary site is the major obstacle to improve cure rates. 
The extent of surgical resection and age were the only statistically significant prognostic factors.

Keywords: chemotherapy, children, intracranial ependymoma, radiotherapy, survival

Copyright © 2004 Kluwer Academic Publishers. All rights reserved

Source: http://ipsapp009.kluweronline.com/IPS/content/ext/x/J/5042/I/119/A/9/abstract.htm


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP